Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer

1. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns, GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990; 34:774-8.10.1038/343774a0Search in Google Scholar

2. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994; 84: 3071-9.10.1182/blood.V84.9.3071.3071Search in Google Scholar

3. Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T, et al. Wilms’ tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998; 91:2969-76.10.1182/blood.V91.8.2969.2969_2969_2976Search in Google Scholar

4. Chen Z. The possible role and application of WT1 in human leukemia. Int J Hematol. 2001; 73:39-46.10.1007/BF02981901Open DOISearch in Google Scholar

5. Algar E, Khromykh T, Smith S, Blackburn D, Bryson G, Smith P. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene. 1996; 12:1005-14.Search in Google Scholar

6. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, et al. Growth inhibition of human leukemic cells by WT1 (Wilms’ tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood. 1996; 87:2878-84.10.1182/blood.V87.7.2878.bloodjournal8772878Search in Google Scholar

7. Smith SI, Down M, Boyd AW, Li CL. Expression of the Wilms’ tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice. Cancer Res. 2000; 60:808-14.Search in Google Scholar

8. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, et al. Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumor despite tumor specific promoter methylation. Cancer Res. 2001; 61: 921-5.Search in Google Scholar

9. Navakanit R, Graidist P, Leeanansaksiri W, Dechsukum C. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilm tumor 1 gene. J Med Assoc Thai. 2007; 90:2416-21.Search in Google Scholar

10. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms’ tumor gene WT1. Proc Natl Acad Sci USA. 1991; 88:9618-22.10.1073/pnas.88.21.9618Search in Google Scholar

11. Yang L, Han Y, Saurez Saiz F, Minden MD. A tumor suppressor and oncogene: the WT1 story. Leukemia. 2007; 21:868-76.10.1038/sj.leu.2404624Search in Google Scholar

12. Wang ZY, Qiu QQ, Deuel TF. The Wilms’ tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem. 1993; 268:9172-5.10.1016/S0021-9258(18)98329-8Search in Google Scholar

13. Dechsukhum C, Ware JL, Ferreira-Gonalez A, Wilkinson DS, Garrett CT. Detection of novel truncated WT1 transcription in human neoplasia. Mol Diag. 2000; 5: 1-12.10.2165/00066982-200005020-00005Search in Google Scholar

14. Loeb DM. WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members. Cell Cycle. 2006; 5:1249-53.10.4161/cc.5.12.280716760668Search in Google Scholar

15. Ito K, Oji Y, Tatsumi N, Shimizu S, Kanai Y, Nakazawa T, et al. Antiapoptotic function of 17AA(+)WT1 (Wilms’ tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene. 2006; 25:4217-29.10.1038/sj.onc.120945516518414Search in Google Scholar

16. Burwell EA, McCarty GP, Simpson LA, Thompson KA, Loeb DM. Isoforms of Wilms’ tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene. 2007; 26:3423-30.10.1038/sj.onc.121012717160023Search in Google Scholar

17. Simpson LA, Burwell EA, Thompson KA, Shahnaz S, Chen AR, Loeb DM. The antiapoptotic gene A1/BEFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy. Blood. 2006; 107:4695-702.10.1182/blood-2005-10-4025189580516484585Search in Google Scholar

18. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature. 2000; 407:642-5.10.1038/3503660811034214Search in Google Scholar

19. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez- Guisa JM, Madden SL, Rauscher FJ, et al. DNA recognition by splicing variant of the Wilms’ tumor suppressor, WT1. Mol Cell Biol. 1994; 14:3800-9.10.1128/MCB.14.6.3800Search in Google Scholar

20. Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA. WT1 induces expression of insulin-like growth factor 2 in Wilms’ tumor cells. Cancer Res. 1995; 55:4540-3.Search in Google Scholar

21. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, et al. RNA binding by the Wilms’ tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA. 1996; 93:7562-6.10.1073/pnas.93.15.7562387858755514Open DOISearch in Google Scholar

22. Hohenstein P, Hastie DN. The many facets of the Wilms’ tumour gene, WT1. Hum Mol Genet. 2006; 2: R196-201.10.1093/hmg/ddl19616987884Open DOISearch in Google Scholar

23. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, et al. Wilms’ tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci. 2006; 97: 259-70.10.1111/j.1349-7006.2006.00169.x16630117Search in Google Scholar

24. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al. Expression of the Wilm’s tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res. 1999; 90:194-204.10.1111/j.1349-7006.1999.tb00733.x592605510189890Search in Google Scholar

25. Tatsumi N, Oji Y, Tsuji N, Tsuda A, Higashio M, Aoyagi S, et al. Wilms’ tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. Int J Oncol. 2008; 32:701-11.10.3892/ijo.32.3.701Search in Google Scholar